Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NAVISCORE Post-Market Clinical Follow-up Study

NCT05706805 is registered in ClinicalTrials.gov with Fundación EPIC as lead sponsor.

NCT NCT05706805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05706805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NAVISCORE Post-Market Clinical Follow-up Study
Lead sponsor
Fundación EPIC
Phase
Observational
Overall status
Completed
Start date
January 31, 2023
Completion date
September 27, 2023
Enrollment
54 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, ischemic heart disease